CTRI/2024/04/065396
Not yet recruiting
未知
A Randomized Clinical Study On Dyslipidaemia and Comparative Evaluation Of Unani Formulation With Rosuvastatin In Its Management - NI
Department of Moalejat Faculty of unani medicine Ajmal khan tibbya college0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Moalejat Faculty of unani medicine Ajmal khan tibbya college
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients in age group of 30\-60 years
- •Patients of either gender
- •Patient willing to sign the written informed consent
- •Clinically stable patients of dyslipidemia with following subjective and
- •objective parameters
- •Subjective parameters:
- •Patient showing any one of the following symptoms will be asked to go for required
- •investigations \& will be included in the study accordingly.
- •Increasing body weight
- •Dyspnoea on exertion
Exclusion Criteria
- •Patient below 30 years and above 60 years
- •Any uncontrolled systemic illness
- •Any type of liver disease
- •Patient of CAD
- •Uncontrolled type 2 Diabetes Mellitus
- •Hyperthyroidism and Hypothyroidism
- •Pregnant and lactating women
- •Patient who fails to give consent
- •In case of worsening of symptoms patient may be withdrawn from trial and
- •be shifted to standard treatment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)JPRN-UMIN000051501TOKYO CENTER CLINIC180
Completed
Not Applicable
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.DyslipidemiaJPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350
Completed
Not Applicable
Study in patients of increased blood cholesterolHealth Condition 1: null- patients of hypercholesterolemia eligible for statin therapyCTRI/2016/11/007486All India Institute of Medical Sciences AIIMS
Recruiting
Phase 4
Effect of Fucus homoeopathic medicine in High blood cholesterol levelsCTRI/2024/01/062141VINAYAKA MISSIONS HOMEOPATHIC MEDICAL COLLEGE AND HOSPITA
Completed
Not Applicable
Investigation for the effect of anti-dyslipidemic drugs on serum level of trans-fatty acidsdyslipidemiaJPRN-UMIN000026984Kobe University Graduate School of Medicine40